Schedule 13G ownership disclosure
20/20 BIOLABS INC
Common Stock, par value $0.01 · CUSIP: 90138K101
Event date: 2026-02-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Full Succeed International Limited
Shares: 651,465.00 · Class: 6.3%
- Nengyuan Pan
Shares: 651,465.00 · Class: 6.3%
- Wei Lu
Shares: 651,465.00 · Class: 6.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-26-025773
- Form type
- SCHEDULE 13G
- Filer
- 20/20 Biolabs, Inc.
- CIK
- CIK 1139685
- Filed
- Mar 10, 2026
- Reporting period
- Feb 19, 2026
- Description
- Schedule 13G beneficial ownership